The Global Drug Delivery Technologies Market Will Reach $259.1bn in 2020

Wednesday 31 August 2016, Amsterdam

A new report, now available on ASDReports, predicts that the Global Drug Delivery Technologies market will reach $259.1bn in 2020. This forecast and others appear in Drug Delivery Technologies Market Forecast 2016-2026: Analysis of Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular and Nasal/Buccal Drug Delivery Technologies; Forecasts for Biologics, Vaccines and Major National Markets and Assessment of Leading Drug Delivery Companies including 3M, BD and Alkermes published in July 2016.

Drug Delivery Technologies Market Forecast 2016-2026: Analysis of Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular and Nasal/Buccal Drug Delivery Technologies; Forecasts for Biologics, Vaccines and Major National Markets and Assessment of Leading Drug Delivery Companies including 3M, BD and Alkermes report examines the current and future trends in the growing drug delivery technologies market. As the generic drug industry continues to see rapid growth, big pharma companies will continue to strive for extensions on their product life-cycles. Drug delivery technologies are of high demand not only because of the deep interest shown by pharma companies in recent years but also the dire need to improve patient compliance. Yemi Adebayo, a Pharmaceutical and Medical Devices Analyst at visiongain comments:

“Drug delivery technologies provide ample opportunities for both biopharmaceutical companies that offer services providing new technologies and pharmaceutical companies attempting to extend the product lifecycle of their product. The drug delivery technologies market will see fast growth over the next ten years. The oral drug delivery market remains the most dominant submarket, which is largely due to the convenience of taking drugs orally. However, with increasing numbers of biologic medicines we expect to see the injectable drug delivery tech market grow rapidly over the forecast period. The problem with using the parenteral route for drug delivery is the inconvenience it brings to patients. As such, novel ways of administering biologics will be sought. This, together with the growing burden of an ageing population and rise in chronic diseases in most developed countries will continue to cause demand for new ways of delivering drugs to their intended target.”

In this report, we examine in detail the drug delivery technologies market, and provide analyses and forecasts for regional and national markets. Historical revenues have also been added to strengthen our analysis to demonstrate how this market has changed. Qualitative analysis of the market is given, taking into account governmental policy and regulation, safety, features and more.